Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Autolus Therapeutics (AUTL) Assets Average (2017 - 2025)

Historic Assets Average for Autolus Therapeutics (AUTL) over the last 9 years, with Q3 2025 value amounting to $691.5 million.

  • Autolus Therapeutics' Assets Average fell 1773.72% to $691.5 million in Q3 2025 from the same period last year, while for Sep 2025 it was $691.5 million, marking a year-over-year decrease of 1773.72%. This contributed to the annual value of $579.1 million for FY2024, which is 3378.38% up from last year.
  • Latest data reveals that Autolus Therapeutics reported Assets Average of $691.5 million as of Q3 2025, which was down 1773.72% from $733.7 million recorded in Q2 2025.
  • In the past 5 years, Autolus Therapeutics' Assets Average registered a high of $877.5 million during Q2 2024, and its lowest value of $288.9 million during Q3 2022.
  • In the last 5 years, Autolus Therapeutics' Assets Average had a median value of $428.5 million in 2023 and averaged $516.7 million.
  • In the last 5 years, Autolus Therapeutics' Assets Average surged by 10604.71% in 2024 and then tumbled by 1773.72% in 2025.
  • Autolus Therapeutics' Assets Average (Quarter) stood at $351.1 million in 2021, then grew by 7.39% to $377.1 million in 2022, then rose by 3.63% to $390.7 million in 2023, then soared by 106.05% to $805.1 million in 2024, then fell by 14.12% to $691.5 million in 2025.
  • Its Assets Average was $691.5 million in Q3 2025, compared to $733.7 million in Q2 2025 and $764.5 million in Q1 2025.